Charlie Lee (Talk | contribs) |
|||
Line 1: | Line 1: | ||
{{SSHS-Shenzhen/CSS}} | {{SSHS-Shenzhen/CSS}} | ||
− | |||
<html lang="en"> | <html lang="en"> | ||
<head> | <head> | ||
− | + | <meta charset="utf-8"> | |
− | + | <title>title</title> | |
<style> | <style> | ||
+ | .header li a:hover,.dropdown:hover.dropbtn { | ||
+ | color: #fff; | ||
+ | } | ||
+ | .header { | ||
+ | font-size: 30px; | ||
+ | padding: 0px; | ||
+ | margin: 0px; | ||
+ | top: 0; | ||
+ | left: 0; | ||
+ | width: 100%; | ||
+ | position: fixed; | ||
+ | height: 3em; | ||
+ | z-index: 99; | ||
+ | float: left; | ||
+ | background-color: #5d8aa8; | ||
+ | min-width: 1080px; | ||
+ | } | ||
+ | body { | ||
+ | background-color: #fff; | ||
+ | } | ||
+ | .dropdown-content { | ||
+ | display: none; | ||
+ | position: absolute; | ||
+ | background-color: #5d8aa8; | ||
+ | min-width: 250px | ||
+ | } | ||
+ | .dropdown-content a { | ||
+ | color: #f7f7f7; | ||
+ | padding: 12px 16px; | ||
+ | text-decoration: none; | ||
+ | display: block; | ||
+ | font-size: 20px; | ||
+ | } | ||
+ | .header li a,.dropbtn,.header a:link, .header a:visited { | ||
+ | color: #f7f7f7; | ||
+ | } | ||
+ | #para{ | ||
+ | color: #000; | ||
+ | padding:30px 100px 5px; | ||
+ | font-size: 20px!important; | ||
+ | } | ||
+ | #fig{ | ||
+ | color: #000; | ||
+ | padding:30px 100px 5px; | ||
+ | font-size: 20px!important; | ||
+ | text-align: center !important; | ||
+ | } | ||
+ | |||
h1{ | h1{ | ||
− | color: # | + | color: #000; |
padding:150px 50px 5px!important; font-size: 30px!important; text-align: center; | padding:150px 50px 5px!important; font-size: 30px!important; text-align: center; | ||
+ | } | ||
+ | |||
+ | h2{ | ||
+ | color: #000; | ||
+ | padding:100px 100px 5px; | ||
+ | font-size: 25px!important; | ||
+ | text-align: left; | ||
+ | line-height: 120%; | ||
+ | } | ||
+ | |||
+ | h3{ | ||
+ | color: #000; | ||
+ | padding:100px 100px 5px; | ||
+ | font-size: 25px!important; | ||
+ | text-align: center; | ||
+ | line-height: 120%; | ||
+ | } | ||
+ | |||
+ | .banner2{ | ||
+ | color:#fff; | ||
+ | background-color:#5d8aa8; | ||
+ | font-size:100px!important; | ||
+ | width:100%; height:500px; | ||
+ | text-align:center; | ||
+ | line-height: 500px; | ||
+ | padding:90px 0px 0px; | ||
+ | background-image:url("https://static.igem.org/mediawiki/2018/c/c7/T--SSHS-Shenzhen--demo1.jpg"); | ||
+ | background-size:cover; | ||
} | } | ||
</style> | </style> |
Revision as of 12:32, 16 October 2018
RNAi efficiency test
After finishing the vitro transcription, we put the adult P. striolata into glass bottles for doing the RNAi efficiency test.
Fig.5-1 Adult P. striolata and Brassica chinensis leaves were placed in the glass bottles. The solutions of siRNA/shRNA (10 ng/mL) were separately sprayed onto the leaves of Chinese cabbage every third day, each solution has two repeats. Around twenty adult beetles of P. striolata were tested per siRNA/shRNA sample.
Table 5-1 RNAi efficiencies of siRNA/shRNA
Fig. 5-2 The survival rate of Phyllotreta striolata at different days after siRNA/ shRNA treatment.
Fig. 5-3 Comparison of RNAi efficiencies between siRNA and shRNA
Fig. 5-4 Comparison of RNAi efficiencies between different shRNAs
Table 5-2 The effect of nucleotide content of shRNA on RNAi efficiency
By comparing the different degrees of decreasing survival rates, between siRNA and shRNA (Fig. 5-2), and between different shRNAs (Fig. 5-3), the RNAi efficiency had been showed. Results show that all the samples tested, except ALR-siRNA-1, and AlR-shRNA-1, could trigger RNAi mechanism, which was demonstrated by the survival rate decrease after treatment (Table 5-1, Fig. 5-1). After 11 days of treatment, there was a slight decrease of survival rate in water treatment (100% to 94%), in ALR-siRNA-1 (100%-81%) and in ALR-shRNA-1(100%-100%). The survival rate decrease of other treatments are significant (between 34.5%-85%). The differences of RNAi efficiency between siRNA and its corresponding shRNA, which have the same target site, are not significant (Fig. 5-2). But the nucleotide content of siRNA/shRNA seems play a role in RNAi efficiency (Fig. 5-3). When the antisense strand of the siRNA/shRNA has a weak base pairing at 3′-end (presence of A/U), but a strong base pairing at 5′-end (presence of G/C), such as ALR-siRNA-1 and ALR-shRNA-1 (Table 5-3), the RNAi efficiency of this siRNA/shRNA is very low. This result may be caused by the failure of the antisense strand to be loaded into RNA-induced silencing complex (RISC), due to the lower free energy level at the 5’end comparing to that at the 3’end.